Stockscreener 앱 받기
43.60
7.44%
3.02
시장 영업 전:
43.00
-0.60
-1.38%
전일 마감가:
$40.58
열려 있는:
$41.14
하루 거래량:
663.51K
Relative Volume:
0.89
시가총액:
$3.29B
수익:
$399.58M
순이익/손실:
$-54.04M
주가수익비율:
-58.13
EPS:
-0.75
순현금흐름:
$40.13M
1주 성능:
+6.19%
1개월 성능:
+6.63%
6개월 성능:
+88.09%
1년 성능:
+70.78%
1일 변동 폭
$41.13
$43.68
1주일 범위
$40.29
$43.68
52주 변동 폭
$18.61
$46.00
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
43.60 | 3.29B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
573.06 | 219.20B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
244.11 | 176.31B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
152.57 | 43.57B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
205.69 | 37.33B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
427.33 | 34.99B | 3.84B | 866.24M | 792.60M | 10.37 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
AMI Asset Management Corp Lowers Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Avanza Fonder AB Makes New $1.38 Million Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Stock Rating Upgraded by StockNews.com - MarketBeat
First Week of September 19th Options Trading For Veracyte (VCYT) - Nasdaq
Veracyte Inc (VCYT) Shares Gap Down to $40.865 on Jan 14 - GuruFocus.com
Harbor Capital Advisors Inc. Reduces Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Catherine Wood's Strategic Reduction in Veracyte Inc Shares - GuruFocus.com
Diversified Trust Co Cuts Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability - Yahoo Finance
Veracyte Gains 44% in a Year: What's Driving the Stock? - MSN
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks - Yahoo Finance
Veracyte director Karin Eastham sells shares worth $403,005 By Investing.com - Investing.com Australia
Insider Selling: Veracyte, Inc. (NASDAQ:VCYT) Director Sells 10,000 Shares of Stock - MarketBeat
Veracyte director Karin Eastham sells shares worth $403,005 - Investing.com
Veracyte Inc (VCYT) Stock Price Up 3.58% on Jan 6 - GuruFocus.com
Principal Financial Group Inc. Lowers Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now - MSN
Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) Target Price at $41.13 - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Sees Significant Decrease in Short Interest - MarketBeat
Stifel Financial Corp Sells 19,420 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Shares Gap DownShould You Sell? - MarketBeat
Geode Capital Management LLC Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Barclays PLC Buys 85,033 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
HighTower Advisors LLC Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
HighTower Advisors LLC Takes $554,000 Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
Veracyte CEO Marc Stapley sells shares worth $242,736 By Investing.com - Investing.com Canada
Veracyte CEO Marc Stapley sells shares worth $242,736 - Investing.com India
Lord Abbett & CO. LLC Purchases New Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte - Yahoo Finance
3 Medical Instruments Industry Stocks To Buy On The GenAI Wave - Barchart
Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Fmr LLC - MarketBeat
US Exchange: 3 Stocks That May Be Trading Below Fair Value - Simply Wall St
Jane Street Group LLC Raises Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - MSN
Veracyte (VCYT) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics - Yahoo! Voices
Veracyte (VCYT) Shares Rebounded in Q3 - Insider Monkey
Neo Ivy Capital Management Buys Shares of 24,116 Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Yahoo Finance
Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% - Yahoo Finance
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Yahoo Finance
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Veracyte Inc 주식 (VCYT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| EASTHAM KARIN | Director |
Jan 02 '25 |
Option Exercise |
5.28 |
10,000 |
52,800 |
28,497 |
| EASTHAM KARIN | Director |
Jan 02 '25 |
Sale |
40.30 |
10,000 |
403,006 |
18,497 |
2.28%
자본화:
|
볼륨(24시간):